Transmedics Group Stock Price on December 23, 2024
TMDX Stock | USD 63.90 1.25 2.00% |
Below is the normalized historical share price chart for TransMedics Group extending back to May 02, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TransMedics stands at 63.90, as last reported on the 26th of December, with the highest price reaching 63.95 and the lowest price hitting 61.47 during the day.
If you're considering investing in TransMedics Stock, it is important to understand the factors that can impact its price. TransMedics Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.24, which indicates the firm had a -0.24% return per unit of risk over the last 3 months. TransMedics Group exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TransMedics' Variance of 28.93, coefficient of variation of (442.59), and Risk Adjusted Performance of (0.17) to confirm the risk estimate we provide.
At this time, TransMedics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 741.3 M in 2024, whereas Common Stock is likely to drop slightly above 375.9 M in 2024. . At this time, TransMedics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 2.88 in 2024, whereas Price To Sales Ratio is likely to drop 10.09 in 2024. TransMedics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of May 2019 | 200 Day MA 120.5656 | 50 Day MA 86.5243 | Beta 2.071 |
TransMedics |
Sharpe Ratio = -0.2418
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TMDX |
Estimated Market Risk
5.29 actual daily | 47 53% of assets are more volatile |
Expected Return
-1.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TransMedics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TransMedics by adding TransMedics to a well-diversified portfolio.
Price Book 10.2162 | Enterprise Value Ebitda 36.0085 | Price Sales 5.3469 | Shares Float 32.5 M | Wall Street Target Price 102 |
TransMedics Main Headline on 23rd of December 2024
TransMedics to Participate in the 43rd Annual J.P. Morgan He... by finance.yahoo.com
TransMedics Group, Inc. , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 13, 2025, at 215 p.m. Pacific Standard Time 515 p.m. Eastern Standard Time.
TransMedics Valuation on December 23, 2024
It is possible to determine the worth of TransMedics on a given historical date. On December 23, 2024 TransMedics was worth 63.33 at the beginning of the trading date compared to the closed value of 62.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TransMedics stock. Still, in general, we apply an absolute valuation method to find TransMedics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TransMedics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TransMedics' related companies.
Open | High | Low | Close | Volume | |
60.00 | 62.50 | 59.72 | 61.70 | 1,596,180 | |
12/23/2024 | 63.33 | 63.74 | 61.79 | 62.65 | 929,388 |
62.90 | 63.95 | 61.47 | 63.90 | 438,463 |
Backtest TransMedics | | | TransMedics History | | | TransMedics Valuation | Previous | Next |
TransMedics Trading Date Momentum on December 23, 2024
On December 24 2024 TransMedics Group was traded for 63.90 at the closing time. The top price for the day was 63.95 and the lowest listed price was 61.47 . The trading volume for the day was 438.5 K. The trading history from December 24, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 2.00% . The trading price change against the current closing price is 0.40% . |
TransMedics Group Fundamentals Correlations and Trends
By evaluating TransMedics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TransMedics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TransMedics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TransMedics Stock history
TransMedics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TransMedics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TransMedics Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TransMedics stock prices may prove useful in developing a viable investing in TransMedics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 32.5 M | 24.3 M | |
Net Loss | -32.6 M | -34.2 M |
TransMedics Quarterly Net Working Capital |
|
TransMedics Stock Technical Analysis
TransMedics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TransMedics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
TransMedics Group cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
TransMedics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how TransMedics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TransMedics shares will generate the highest return on investment. By undertsting and applying TransMedics stock market strength indicators, traders can identify TransMedics Group entry and exit signals to maximize returns
TransMedics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TransMedics' price direction in advance. Along with the technical and fundamental analysis of TransMedics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TransMedics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.17) | |||
Jensen Alpha | (1.29) | |||
Total Risk Alpha | (1.46) | |||
Treynor Ratio | (0.69) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.